In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.
Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology, University of Tuebingen, Hoppe Seyler-Strasse 3, 72076, Tuebingen, Germany, Walter.maetzler@uni-tuebingen.de.
Walter
W
Maetzler
Andrea
A
Pilotto
Anja
A
Apel
Christian
C
Deuschle
Gabriele
G
Kuebart
Sebastian
S
Heinzel
Inga
I
Liepelt-Scarfone
Claudia
C
Schulte
Dorothee
D
Reusch
Erwin
E
Schleicher
Oliver
O
Rothfuss
Anja
A
Schneider
Richard
R
Dodel
Thomas
T
Gasser
Daniela
D
Berg
D000368:Aged; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D020961:Lewy Body Disease / Q000097:blood* / Q000134:cerebrospinal fluid / Q000175:diagnosis; D008297:Male; D010300:Parkinson Disease / Q000097:blood* / Q000134:cerebrospinal fluid / Q000175:diagnosis; D010446:Peptide Fragments / Q000134:cerebrospinal fluid; D012720:Severity of Illness Index; D051844:alpha-Synuclein / Q000097:blood*; D016875:tau Proteins / Q000134:cerebrospinal fluid
D016229:Amyloid beta-Peptides; D001323:Autoantibodies; D015415:Biomarkers; C054369:MAPT protein, human; D010446:Peptide Fragments; C497604:SNCA protein, human; D051844:alpha-Synuclein; C075222:amyloid beta-protein (1-42); D016875:tau Proteins